Skip to content

Debt-to-assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×+0.1×
ALN
Alnylam PharmaceuticalsALNY
0.1×0.0×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
2.4×+2.4×
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
0.3×+0.2×
Royalty Pharma logo
Royalty PharmaRPRX
0.5×0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

Based on the most recent quarter.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's debt-to-assets?
Arrowhead Research (ARWR) reported debt-to-assets of 0× in Q1 2026.
How has Arrowhead Research's debt-to-assets changed year-over-year?
Arrowhead Research's debt-to-assets decreased by 34.4% year-over-year, from 0.1× to 0×.
What is the long-term trend for Arrowhead Research's debt-to-assets?
Over 5 years (2020 to 2025), Arrowhead Research's debt-to-assets has grown at a 14.7% compound annual growth rate (CAGR), from 0× to 0.1×.
What does debt-to-assets mean?
What fraction of everything the company owns is funded by debt.
How do you interpret debt-to-assets?
A lower ratio indicates a more conservatively financed balance sheet. Rising debt-to-assets over time signals increasing financial risk.
How does debt-to-assets compare across companies?
Comparable within an industry; bounded between 0 and 1 for most non-financials, which makes cross-company reads cleaner than debt-to-equity.